[1] Song Y, Tran M, Wang L, et al.MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis. Lab Invest,2022,102(5):485-493.
[2] 冯茂森,马文斌,汤善宏,等.先天性肝纤维化的发病机制及诊治现状[J].临床肝胆病杂志,2017,33(3):553-557.
[3] Alsomali MI, Yearsley MM, Levin DM, et al. Diagnosis of Congenital Hepatic Fibrosis in Adulthood[J]. American Journal of Clinical Pathology, 2020, 153(1):119-125.
[4] 王君,舒娟,吴凡,等.经颈静脉肝内门体分流术诊治先天性肝纤维化1例[J].中华肝脏病杂志,2021,29(4):373-376.
[5] 廖伊梅,文华轩,李胜利.先天性胆管扩张症与Caroli病[J].中华医学超声杂志(电子版),2019,16(7):555-559.
[6] Cordido A,Vizoso-Gonzalez M,Garcia-Gonzalez MA.Molecular pathophysiology of autosomal recessive polycystic kidney disea-se[J]. International Journal of Molecular Sciences, 2021,22(12):6523.
[7] Bhatia V, Bavdekar A, Matthai J, et al. Management of neonatal cholestasis: Consensus statement of the pediatric gastroenterology chapter of Indian academy of pediatrics[J]. Indian pediatrics, 2014, 51(3):203-210.
[8] Shorbagi A. Experience of a single center with congenital hepatic fibrosis: A review of the literature[J]. World Journal of Gastroenterology, 2010, 16(6):683.
[9] Kerr D NS, Warrick CK, Hart-Mercer J. A lesion resembling medullary sponge kidney in patients with congenital hepatic fibro-sis[J]. Clinical Radiology, 1962, 13(2):85-91.
[10] 刘雯,李丽军,李卫,等.先天性肝纤维化1例[J].肝脏,2015,20(4):340-341.
[11] 赵新颜,王宝恩,贾继东.36例先天性肝纤维化的临床病理特点[J].中华消化杂志,2005(12):748-749.
[12] 任美欣,韩莹,刘晖,等.先天性肝纤维化10例临床分析[J].北京医学,2018,40(4):364-365.
[13] Wu WK, Ziogas IA, Izzy M, et al. Liver transplantation for congenital hepatic fibrosis[J].Transplant International,2021,34(7):1281-1292.